Asian Pacific Journal of Cancer Prevention

  • 제15권10호
  • /
  • Pages.4245-4250
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

miR-186 Regulates Glycolysis through Glut1 During the Formation of Cancer-associated Fibroblasts

  • Sun, Pan (Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine) ;
  • Hu, Jun-Wei (Shanghai East Hospital Affiliated to Tongji University) ;
  • Xiong, Wu-Jun (Shanghai East Hospital Affiliated to Tongji University) ;
  • Mi, Jun (Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine)
  • 발행 : 2014.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Emerging evidence has suggested that glycolysis is enhanced in cancer-associated fibroblasts (CAF), and miR-186 is downregulated during the CAF formation. However, it is not clear whether miR-186 is involved in the regulation of glycolysis and what the role of miR-186 plays during the CAF formation. In this study, quantitative PCR analysises show miR-186 is downregulated during the CAF formation. Moreover, miR-186 targets the 3' UTR of Glut1, and its overexpression results in the degradation of Glut1 mRNA, which eventually reduces the level of Glut1 protein. On the other hand, knockdown of miR-186 increased the expression of Glut1. Both time course and dose response experiments also demonstrated that the protein and mRNA levels of Glut1 increase during CAF formation, according to Western blot and quantitative PCR analyses, respectively. Most importantly, besides the regulation on cell cycle progression, miR-186 regulates glucose uptake and lactate production which is mediated by Glut1. These observations suggest that miR-186 plays important roles in glycolysis regulation as well as cell cycle checkpoint activation.

키워드

참고문헌

  1. Airley RE, Mobasheri A (2007). Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy, 53, 233-56. https://doi.org/10.1159/000104457
  2. Amann T, Hellerbrand C (2009). GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets, 13, 1411-27. https://doi.org/10.1517/14728220903307509
  3. Bagga S, Bracht J, Hunter S, et al (2005). Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell, 122, 553-63. https://doi.org/10.1016/j.cell.2005.07.031
  4. Bhowmick NA, Neilson EG, Moses HL (2004). Stromal fibroblasts in cancer initiation and progression. Nature, 432, 332-7. https://doi.org/10.1038/nature03096
  5. Boire A, Covic L, Agarwal A, et al (2005). PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell, 120, 303-13. https://doi.org/10.1016/j.cell.2004.12.018
  6. Brennecke J, Stark A, Russell RB, Cohen SM (2005). Principles of microRNA-target recognition. PLoS Biol, 3, 85. https://doi.org/10.1371/journal.pbio.0030085
  7. Cai J, Wu J, Zhang H, et al (2013). miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res, 73, 756-66. https://doi.org/10.1158/0008-5472.CAN-12-2651
  8. Calin GA, Croce CM (2006a). MicroRNA-cancer connection: the beginning of a new tale. Cancer Res, 66, 7390-4. https://doi.org/10.1158/0008-5472.CAN-06-0800
  9. Calin GA, Croce CM (2006b). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66. https://doi.org/10.1038/nrc1997
  10. Dimanche-Boitrel MT, Vakaet L Jr, Pujuguet P, et al (1994). In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int J Cancer, 56, 512-21. https://doi.org/10.1002/ijc.2910560410
  11. Farh KK, Grimson A, Jan C, et al (2005). The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science, 310, 1817-21. https://doi.org/10.1126/science.1121158
  12. Grum-Schwensen B, Klingelhofer J, Berg CH, et al (2005). Suppression of tumor development and metastasis formation in mice lacking the S100A4 (mts1) gene. Cancer Res, 65, 3772-80. https://doi.org/10.1158/0008-5472.CAN-04-4510
  13. Huang F, Lin C, Shi YH, Kuerban G (2013). MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells. Asian Pac J Cancer Prev, 14, 5915-20. https://doi.org/10.7314/APJCP.2013.14.10.5915
  14. Kim SY, Lee YH, Bae YS (2012). MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting alpha subunit of protein kinase CKII in human colorectal cancer cells. Biochem Biophys Res Commun, 429, 173-9. https://doi.org/10.1016/j.bbrc.2012.10.117
  15. Kuperwasser C, Chavarria T, Wu M, et al (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA, 101, 4966-71. https://doi.org/10.1073/pnas.0401064101
  16. Lai EC (2004). Predicting and validating microRNA targets. Genome Biol, 5, 115. https://doi.org/10.1186/gb-2004-5-9-115
  17. Lewis BP, Burge CB, Bartel DP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20. https://doi.org/10.1016/j.cell.2004.12.035
  18. Li H, Yin C, Zhang B, et al (2013a). PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186. Carcinogenesis, 34, 2145-55. https://doi.org/10.1093/carcin/bgt158
  19. Li Q, Zhang D, Wang Y, et al (2013b). MiR-21/Smad 7 signaling determines TGF-beta1-induced CAF formation. Scientific Reports, 3, 2038.
  20. Lim LP, Lau NC, Garrett-Engele P, et al (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-73. https://doi.org/10.1038/nature03315
  21. Lochter A, Galosy S, Muschler J, et al (1997). Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-tomesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol, 139, 1861-72. https://doi.org/10.1083/jcb.139.7.1861
  22. Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8. https://doi.org/10.1038/nature03702
  23. Mathupala SP, Ko YH, Pedersen PL (2009). Hexokinase-2 bound to mitochondria: cancer's stygian link to the “Warburg Effect” and a pivotal target for effective therapy. Semin Cancer Biol, 19, 17-24. https://doi.org/10.1016/j.semcancer.2008.11.006
  24. Olaso E, Santisteban A, Bidaurrazaga J, et al (1997). Tumordependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology, 26, 634-42.
  25. Olsen PH, Ambros V (1999). The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol, 216, 671-80. https://doi.org/10.1006/dbio.1999.9523
  26. Olumi AF, Grossfeld GD, Hayward SW, et al (1999). Carcinomaassociated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res, 59, 5002-11.
  27. Orimo A, Gupta PB, Sgroi DC, et al (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 121, 335-48. https://doi.org/10.1016/j.cell.2005.02.034
  28. Sternlicht MD, Lochter A, Sympson CJ, et al (1999). The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell, 98, 137-46. https://doi.org/10.1016/S0092-8674(00)81009-0
  29. Stetler-Stevenson WG, Aznavoorian S, Liotta LA (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol, 9, 541-73. https://doi.org/10.1146/annurev.cb.09.110193.002545
  30. Wan SM, Lv F, Guan T (2012). Identification of genes and microRNAs involved in ovarian carcinogenesis. Asian Pac J Cancer Prev, 13, 3997-4000. https://doi.org/10.7314/APJCP.2012.13.8.3997
  31. Wang Y, Stricker HM, Gou D, Liu L (2007). MicroRNA: past and present. Front Biosci, 12, 2316-29. https://doi.org/10.2741/2234
  32. Warburg O (1956). [Origin of cancer cells]. Oncologia, 9, 75-83. https://doi.org/10.1159/000223920
  33. Xie X, Lu J, Kulbokas EJ, et al (2005). Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature, 434, 338-45. https://doi.org/10.1038/nature03441
  34. Yang JH, Li JH, Shao P, et al (2011). starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic acids research, 39, 202-9. https://doi.org/10.1093/nar/gkq760

피인용 문헌

  1. MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1 vol.8, pp.1, 2015, https://doi.org/10.1186/s13048-015-0207-6
  2. miR-186 in Alzheimer's disease: a big hope for a small RNA? vol.137, pp.3, 2016, https://doi.org/10.1111/jnc.13573
  3. MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1 vol.37, pp.5, 2016, https://doi.org/10.1007/s13277-015-4558-9
  4. CAF cellular glycolysis: linking cancer cells with the microenvironment vol.37, pp.7, 2016, https://doi.org/10.1007/s13277-016-5049-3
  5. MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis vol.8, pp.5, 2017, https://doi.org/10.1038/cddis.2017.60
  6. Genetic alterations and epigenetic alterations of cancer-associated fibroblasts vol.13, pp.1, 2017, https://doi.org/10.3892/ol.2016.5451
  7. MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of pancreatic cancer vol.14, pp.3, 2017, https://doi.org/10.3892/etm.2017.4770
  8. MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C vol.14, pp.4, 2017, https://doi.org/10.3892/etm.2017.4908
  9. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts vol.2018, pp.2314-6141, 2018, https://doi.org/10.1155/2018/6075403